HRAS and ameloblastoma: However, other Authors showed additional mutations to B-Raf in ameloblastomas, such as NRAS, HRAS, KRAS, FGFR2, and PIK3CA,10,23,44 suggesting they may represent secondary mutations occurring later in the pathogenesis of ameloblastoma.